FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND
EIN 45-0524687 COLUMBIA, MD
- Revenue 2024
- $7,006,271
- Expenses 2024
- $2,441,051
Program services were 98.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- H11
- Classification
- 1000
- Street
- 6925 OAKLAND MILLS ROAD 701
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2024
Mission
THE FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND'S MISSION IS TO ACCELERATE THE TRANSLATION OF RETINAL LABORATORY-BASED RESEARCH INTO CLINICAL TRIALS TO EXPEDITE THE COMMERCIALIZATION OF PATIENT THERAPIES.
Activities or mission (Part I)
SEE SCHEDULE O
-
THE FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND (RD FUND) AIMS TO DELIVER LIFE-CHANGING SOLUTIONS FOR INDIVIDUALS WITH RETINAL DEGENERATIVE DISEASES TODAY, WHILE CREATING A PIPELINE OF NEXT-GENERATION AND NOVEL THERAPEUTIC OPPORTUNITIES FOR TOMORROW. RD FUND IS FLEXIBLE IN HOW IT STRUCTURES INVESTMENTS LEVERAGING EQUITY, DEBT, ROYALTY, AND/OR PROJECT CO-FUNDING. ALL PROCEEDS OF THIS HIGH-IMPACT PHILANTHROPIC VEHICLE ARE RETURNED TO THE FOUNDATION TO PROVIDE RESOURCES FOR FURTHERING ITS MISSION. RD FUND ACCOMPLISHES THIS BY INVESTING IN EARLY STAGE BIOTECHNOLOGY COMPANIES THAT ARE FOCUSED ON ADVANCING PROMISING THERAPIES FOR RETINAL DEGENERATIVE DISEASES.
Expenses $2,402,495 · Grants $1,000,000
As filed on the 2024 return.
Officers and directors · 2024
As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
ADRIENNE GRAVES PHD
CHAIRMAN
- Total calculated
- $12,500
- From this org
- $12,500
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1 + 1 related
-
KAREN PETROU
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 1 + 10 related
-
TONY ADAMIS MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JEAN BENNETT MD PHD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
MARK BLUMENKRANZ MD MMS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CATHERINE BOWES RICKMAN PHD
DIRECTOR
- Total calculated
- $15,000
- From this org
- $0
- From related orgs
- $15,000
- Other
- $0
- Hours/week
- 1 + 1 related
-
JACQUE DUNCAN MD
DIRECTOR
- Total calculated
- $75,000
- From this org
- $0
- From related orgs
- $75,000
- Other
- $0
- Hours/week
- 1 + 5 related
-
KELLY LISBAKKEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JOSE-ALAIN SAHEL MD
DIRECTOR
- Total calculated
- $15,000
- From this org
- $0
- From related orgs
- $15,000
- Other
- $0
- Hours/week
- 1 + 1 related
-
JONATHAN STEINBERG MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1 + 1 related
-
WARREN THALER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1 + 1 related
-
JASON D MENZO
CEO
- Total calculated
- $723,931
- From this org
- $126,140
- From related orgs
- $504,560
- Other
- $93,231
- Hours/week
- 8 + 32 related
Schedule J breakdown matched by us
- Base
- $88,178 + $352,711 related
- Bonus
- $19,645 + $78,580 related
- Other
- $18,317 + $73,270 related
- Deferred
- $7,107 + $28,430 related
- Nontaxable benefits
- $11,539 + $46,155 related
- Filer's total
- $144,786 + $579,146 related
-
PETER L GINSBERG
COO / ACTING TREASURER, RD FUND
- Total calculated
- $540,342
- From this org
- $91,006
- From related orgs
- $364,025
- Other
- $85,311
- Hours/week
- 8 + 32 related
Schedule J breakdown matched by us
- Base
- $65,948 + $263,793 related
- Bonus
- $8,916 + $35,664 related
- Other
- $16,142 + $64,569 related
- Deferred
- $6,909 + $27,635 related
- Nontaxable benefits
- $10,153 + $40,614 related
- Filer's total
- $108,069 + $432,275 related
-
RUSSELL W KELLEY
MANAGING DIRECTOR, RD FUND
- Total calculated
- $533,294
- From this org
- $447,300
- From related orgs
- $0
- Other
- $85,994
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $326,079
- Bonus
- $42,765
- Other
- $78,456
- Deferred
- $32,428
- Nontaxable benefits
- $53,566
- Filer's total
- $533,294
-
ALICIA KEMBLE
SR. VENTURE ASSOCIATE
- Total calculated
- $212,884
- From this org
- $164,205
- From related orgs
- $0
- Other
- $48,679
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $151,872
- Bonus
- $12,211
- Other
- $122
- Deferred
- $9,665
- Nontaxable benefits
- $39,014
- Filer's total
- $212,884
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2024
- Revenue
- $7,006,271
- Expenses
- $2,441,051
- Contributions
- $8,771,404
- Grants paid
- $1,000,000
-
2023
- Revenue
- $8,751,135
- Expenses
- $1,309,685
- Contributions
- $8,307,442
- Grants paid
- $0
-
2022
- Revenue
- $9,316,837
- Expenses
- $1,014,874
- Contributions
- $14,920,274
- Grants paid
- $0
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $15,424,974
- Expenses
- $1,051,912
- Assets (EOY)
- $45,350,093
-
2021 · 990
- Revenue
- $15,424,974
- Expenses
- $1,051,912
- Assets (EOY)
- $45,350,093
-
2020 · 990
- Revenue
- $21,228,882
- Expenses
- $2,021,967
- Assets (EOY)
- $31,011,511
-
2019 · 990
- Revenue
- $11,939,089
- Expenses
- $2,984,402
- Assets (EOY)
- $11,438,657
-
2017 · 990
- Revenue
- $13,259,129
- Expenses
- $11,809,240
- Assets (EOY)
- $3,894,860
-
2016 · 990
- Revenue
- $5,414,179
- Expenses
- $4,800,240
- Assets (EOY)
- $4,864,479
-
2015 · 990
- Revenue
- $3,694,149
- Expenses
- $3,491,183
- Assets (EOY)
- $2,709,507
-
2014 · 990
- Revenue
- $4,672,253
- Expenses
- $4,606,315
- Assets (EOY)
- $1,333,743
-
2013 · 990
- Revenue
- $4,737,262
- Expenses
- $5,135,614
- Assets (EOY)
- $2,940,657
-
2011 · 990
- Revenue
- not reported
- Expenses
- $3,642,916
- Assets (EOY)
- $1,766,098
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.
Grants made
-
$1,000,000
2024 RESEARCH FUNDING
Grants received
-
FOUNDATION FIGHTING BLINDNESS INC
$14,920,274
2022 RESEARCH
-
FOUNDATION FIGHTING BLINDNESS INC
$8,771,404
2024 RESEARCH
-
FOUNDATION FIGHTING BLINDNESS INC
$8,307,442
2023 RESEARCH
-
2022 For grant recipient's exempt purposes
-
2023 For grant recipient's exempt purposes
-
2024 For grant recipient's exempt purposes
-
2022 UNRESTRICTED GENERAL SUPPORT
Related organizations
From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.
Declared on its 2024 return
-
THE FOUNDATION FIGHTING BLINDNESS INC
501(C)(3) · RESEARCH · MD
-
MACULAR DEGENERATION INTERNATIONAL INC
501(C)(3) · FUNDRAISING · IL
-
NATIONAL RETINITIS PIGMENTOSA FOUNDATION
501(C)(3) · FUNDRAISING · MD
Declared as related by
-
FOUNDATION FIGHTING BLINDNESS INC
On its 2024 return as a controlled entity
Taxable family
From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.
Related corporations and trusts on its 2022 return
-
C · GENE THERAPY · DE · 41.22% owned · share of income $34,580 · share of assets $1,981,206 · controlled entity
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility SOUNK.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 26 October 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.